Literature DB >> 3881457

Adipocyte conversion of CHEF cells in serum-free medium.

J J Harrison, E Soudry, R Sager.   

Abstract

When grown in the presence of serum with added insulin, Chinese hamster embryonic fibroblasts (CHEF/18) cells can be induced to become preadipocytes that are committed to the adipocyte pathway of terminal differentiation (Sager, R., and P. Kovac, 1982, Proc. Natl. Acad. Sci. USA, 79:480-484). We found that commitment to the adipocyte pathway, as well as terminal differentiation to form mature adipocytes, can occur in a defined serum-free medium containing insulin. When CHEF/18 cells are plated in serum-containing medium, only 5-10% of cells in each colony undergo terminal differentiation, whereas in serum-free medium, greater than 90% of the cells became adipocytes. These and other results show that CHEF/18 cells require no adipogenic factors in addition to insulin and the other components of the serum-free medium (transferrin, epithelial growth factor, thrombin) to form adipocytes, and furthermore, that serum inhibits the rate of terminal adipocyte differentiation of these cells. As little as 10 ng/ml insulin added to serum-containing medium can induce adipogenesis, suggesting that insulin rather than an insulinlike growth factor is the active agent. The results further demonstrate that virtually every CHEF/18 cell can be induced into the adipocyte pathway.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881457      PMCID: PMC2113436          DOI: 10.1083/jcb.100.2.429

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  17 in total

1.  Loss of epidermal growth factor requirement and malignant transformation.

Authors:  P V Cherington; B L Smith; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.

Authors:  S M Taylor; P A Jones
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

3.  A serum-free medium for the growth of muscle cells in culture.

Authors:  J R Florini; S B Roberts
Journal:  In Vitro       Date:  1979-12

4.  Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells.

Authors:  L S Wise; H Green
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

Review 5.  Lineages, quantal cell cycles, and the generation of cell diversity.

Authors:  H Holtzer; N Rubinstein; S Fellini; G Yeoh; J Chi; J Birnbaum; M Okayama
Journal:  Q Rev Biophys       Date:  1975-11       Impact factor: 5.318

6.  Adipose conversion of 3T3 cells depends on a serum factor.

Authors:  W Kuri-Harcuch; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Growth hormone and the adipose conversion of 3T3 cells.

Authors:  M Morikawa; T Nixon; H Green
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

8.  Azacytidine-induced tumorigenesis of CHEF/18 cells: correlated DNA methylation and chromosome changes.

Authors:  J J Harrison; A Anisowicz; I K Gadi; M Raffeld; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins.

Authors:  M E Svoboda; J J Van Wyk; D G Klapper; R E Fellows; F E Grissom; R J Schlueter
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

10.  Inhibition of myoblast differentiation in vitro by a protein isolated from liver cell medium.

Authors:  M J Evinger-Hodges; D Z Ewton; S C Seifert; J R Florini
Journal:  J Cell Biol       Date:  1982-05       Impact factor: 10.539

View more
  1 in total

Review 1.  Adipose tissue development: the role of precursor cells and adipogenic factors. Part I: Adipose tissue development and the role of precursor cells.

Authors:  H Hauner; G Löffler
Journal:  Klin Wochenschr       Date:  1987-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.